AstraZeneca shares fall after lung cancer drug underwhelms in trial
LONDON — AstraZeneca said on Monday that a new lung cancer treatment outperformed standard-of-care chemotherapy in a trial, but investors found the results less impressive
LONDON — AstraZeneca said on Monday that a new lung cancer treatment outperformed standard-of-care chemotherapy in a trial, but investors found the results less impressive
Similar to other sectors around the world, the light speed development of artificial intelligence (AI) has made its way into healthcare, particularly the radiology field.
Atom Bioscience has pulled in $83 million in Series D financing for its URAT1 inhibitor for chronic gout, the company announced Monday, with the money